En esta página
01HYPD precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
HYPD Hyperion DeFi, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026
$3,73
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,34mínimo 52 semanas
$11,41máximo 52 semanas
Capitalización Bursátil (MRQ)
$57M
P/E (TTM)
-0.9
BPA (TTM)
$-4.13
Ingresos (TTM)
$1M
tus insignias
Rango 52S
$2–$11
Calificación del Analista
BUY
Precio Objetivo
$10
P/E
-0.9
ROE
9.6%
Margen de Beneficio Neto
474.9%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
HYPD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.73
Capitalización Bursátil (MRQ)
$57M
P/E (TTM)
-0.9
BPA (TTM)
$-4.13
Ingresos (TTM)
$1M
ROE (TTM)
9.6%
Deuda/Capital
0.2
Rango 52S
$2–$11
HYPD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 3 de febrero de 2025 | 1-for-80 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$813.5K2020-12-31 → 2025-12-31
BPA$-9.402020-12-31 → 2025-12-31
Flujo de caja libre·2017-12-31 → 2021-12-31
Margen neto474.9%2020-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | HYPD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -0.9promedio 5A ≈-162.8 | ≈-162.8 | · | · | |
| P/S (TTM) | 40.7 | · | 180.5 | Infravalorado | |
| P/C (MRQ) | 0.6 | · | 0.9 | Infravalorado | |
| EV / EBITDA | -0.7 | · | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -2.2 | · | · | · | |
| EV / Revenue (EV / Ingresos) | 42.1 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.8promedio 5A ≈456.3 | ≈456.3 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | HYPD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Bruto (TTM) | 78.4% | · | · | · | |
| Margen Operativo (TTM) | 314.3% | · | -3838.0% | De primer nivel | |
| EBITDA Margin (Margen EBITDA) | -5743.5% | · | -3573.2% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | 474.9% | · | -1237.2% | De primer nivel | |
| ROA (TTM) | 7.9% | · | -50.9% | Débil | |
| ROE (TTM) | 9.6% | · | -26.5% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | HYPD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Debt / Equity (Deuda / Patrimonio) | 0.2 | · | 0.0 | Deuda alta | |
| Ratio corriente (MRQ) | 2.3 | · | 3.7 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 2.4 | · | 3.7 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | HYPD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 1318.8%promedio 5A ≈1110.9% | ≈1110.9% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -84.0% | · | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -16.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | HYPD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0 | · | 0.0 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$90.4K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
2.1%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $0.93 | $4.80 | -80.6% |
| 31 de marzo de 2026 | May 14, 2026 | $0.26 | $0.14 | 88.8% |
| 31 de diciembre de 2025 | $-7.76 | $-4.71 | -64.7% | |
| 31 de marzo de 2025 | $-1.63 | $-9.79 | 83.4% | |
| 31 de diciembre de 2024 | $-6.93 | $-7.34 | 5.6% | |
| 30 de septiembre de 2024 | $-8.80 | $-10.88 | 19.1% | |
| 30 de junio de 2024 | $-16.80 | $-12.24 | -37.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $813.5K | $57.3K | $3.8K | · | $14M | $2M | |
| Cost of Revenue | $303.3K | $4M | $16.0K | · | $2M | $800.0K | |
| Gross Profit | $510.2K | $-4M | $-12.2K | · | $12M | $1M | |
| R&D Expense | $2M | $14M | $13M | $13M | $15M | $13M | |
| SG&A Expense | $17M | $14M | $12M | $14M | $11M | $8M | |
| Operating Expenses | $47M | $45M | $25M | $27M | $25M | $21M | |
| Operating Income | $-47M | $-49M | $-25M | $-27M | $-13M | $-20M | |
| Interest Expense | · | · | $2M | $1M | $387.8K | $17.0K | |
| Interest Income | $240.0K | $254.0K | $693.6K | · | · | · | |
| Other Non-op | $389.7K | $-90.6K | $-176.4K | $197.1K | $164.0K | · | |
| Income Tax | $-30.9K | · | · | · | · | · | |
| Net Income | $-45M | $-50M | $-27M | $-28M | $-13M | $-20M | |
| EPS (Basic) | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 | $-0.94 | |
| EPS (Diluted) | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 | $-0.94 | |
| Shares (Basic) | 5,000,331 | 832,997 | 512,912 | 33,649,747 | 26,324,081 | 21,054,706 | |
| Shares (Diluted) | 5,000,331 | 832,997 | 512,912 | 33,649,747 | 26,324,081 | 21,054,706 | |
| EBITDA | $-47M | · | · | · | $-13M | $-20M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $2M | $15M | $23M | $19M | $28M | |
| Inventory | · | · | $109.8K | · | · | · | |
| Prepaid Expense | $934.9K | $645.7K | $1M | $1M | $734.9K | $453.5K | |
| Other Current Assets | $404.4K | $97.3K | · | · | · | · | |
| Current Assets | $7M | $3M | $21M | $28M | $22M | $33M | |
| PP&E (Net) | · | · | $3M | $1M | $1M | $396.4K | |
| PP&E (Gross) | · | $6M | $5M | $2M | $2M | $573.3K | |
| Accum. Depreciation | · | $3M | $1M | $635.8K | $328.4K | $176.9K | |
| Intangibles | · | · | $2M | · | · | · | |
| Other Non-current Assets | $230.4K | $182.2K | · | · | · | · | |
| Total Assets | $52M | $4M | $29M | $31M | $32M | $34M | |
| Accounts Payable | $317.9K | $2M | $2M | $1M | $2M | $1M | |
| Short-term Debt | $8M | $11M | $6M | $416.7K | · | $97.5K | |
| Current Liabilities | $3M | $16M | $10M | $5M | $11M | $18M | |
| Capital Leases | $206.6K | $717.5K | $1M | $907.6K | · | · | |
| Total Liabilities | $11M | $17M | $20M | $14M | $11M | $19M | |
| Total Debt | $8M | · | · | · | · | $97.5K | |
| Common Stock | · | $151 | $57 | $3.7K | $2.8K | $2.5K | |
| Paid-in Capital | $282M | $182M | $154M | $135M | $111M | $93M | |
| Retained Earnings | $-241M | $-195M | $-145M | $-118M | $-90M | $-77M | |
| Treasury Stock | $253.6K | · | $5M | $0 | · | · | |
| Stockholders' Equity | $41M | $-13M | $9M | $17M | $20M | $15M | |
| Liabilities + Equity | $52M | $4M | $29M | $31M | $32M | $34M | |
| Shares Outstanding | 8,680,005 | 1,506,369 | 569,409 | 36,668,980 | 28,426,616 | 24,978,585 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | $1M | $783.2K | $307.4K | $221.6K | $95.4K | |
| Stock-based Comp | $6M | $2M | $2M | $4M | $3M | $2M | |
| Other Non-cash | · | · | · | · | $-11M | $11M | |
| Operating Cash Flow | $-15M | $-30M | $-24M | $-25M | $-21M | $-6M | |
| CapEx | · | $161.5K | $3M | $540.4K | $1M | $261.3K | |
| Investing Cash Flow | $-72M | $-161.5K | $-4M | $-874.7K | $-2M | $-261.3K | |
| Net Debt Issued | · | · | · | · | $-66.6K | · | |
| Stock Issued | · | · | · | · | · | $13M | |
| Net Stock Activity | · | · | · | · | · | $13M | |
| Financing Cash Flow | $91M | $18M | $20M | $22M | $21M | $21M | |
| Net Change in Cash | $4M | $-13M | $-8M | $-4M | $-1M | $14M | |
| Taxes Paid | $-8.1K | $36.1K | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $-22M | $-7M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 62.7% | · | · | · | 88.6% | 60.0% | |
| Operating Margin | -5743.5% | · | · | · | -92.2% | -989.5% | |
| Net Margin | -5570.6% | · | · | · | -91.3% | -988.5% | |
| EBITDA Margin | -5743.5% | · | · | · | -90.6% | -984.7% | |
| ROA | -163.5% | · | · | · | -39.0% | -81.3% | |
| ROE | -115.6% | · | · | · | -103.4% | -116.5% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | · | · | · | 2.0 | 1.8 | |
| Quick Ratio | 2.4 | · | · | · | 1.7 | 1.6 | |
| Debt / Equity | 0.2 | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | -33.3 | -1161.2 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.4 | 0.1 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.73 | · | · | · | $0.72 | $0.61 | |
| Revenue / Share | $0.16 | · | · | · | $0.53 | · | |
| Cash Flow / Share | $-2.95 | · | · | · | $-0.79 | · | |
| Cash / Share | $0.74 | · | · | · | $0.68 | $1.14 | |
| EPS (TTM) | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 | $-0.94 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 1318.8% | 1414.0% | · | · | 600.0% | · | |
| Revenue CAGR 3Y | · | -84.0% | -87.6% | · | · | · | |
| Revenue CAGR 5Y | -16.5% | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $813.5K | $57.3K | $3.8K | $0 | $14M | $2M | |
| Net Income TTM | $-45M | $-50M | $-27M | $-28M | $-13M | $-20M | |
| Market Cap | $31M | · | · | · | $9.10B | $12.11B | |
| Enterprise Value | $33M | · | · | · | · | $12.08B | |
| P/E | -0.4 | -0.2 | -3.1 | -157.1 | -653.1 | -515.7 | |
| P/S | 38.0 | · | · | · | 649.8 | 6054.8 | |
| P/B | 0.8 | · | · | · | 444.5 | 791.3 | |
| P / Tangible Book | 0.8 | · | 1102.4 | 277.4 | 444.5 | 791.3 | |
| P / Cash Flow | -2.1 | · | · | · | -435.8 | -1896.8 | |
| P / FCF | · | · | · | · | -411.6 | -1822.2 | |
| EV / EBITDA | -0.7 | · | · | · | · | -613.5 | |
| EV / FCF | · | · | · | · | · | -1818.0 | |
| EV / Revenue | 40.3 | · | · | · | · | 6040.7 | |
| Earnings Yield | -264.0% | -512.1% | -31.9% | -0.64% | -0.15% | -0.19% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $357.7K | $244.3K | $496.2K | $302.5K | $0 | $14.7K | $28.1K | $1.6K | $22.6K | $5.0K | $2.6K | $1.2K | · | · | · | $0 | |
| Cost of Revenue | · | · | $303.2K | $0 | $0 | $48 | $3M | $132.5K | $490.4K | $203.0K | $2.6K | $13.4K | · | · | · | $0 | |
| Gross Profit | $357.7K | $244.3K | $193.0K | $302.5K | $0 | $14.7K | $-3M | $-130.9K | $-467.7K | $-198.0K | $0 | $-12.2K | · | · | · | $0 | |
| R&D Expense | $58.5K | $286.8K | $189.0K | $373.9K | $674.6K | $673.0K | $2M | $3M | $5M | $4M | $4M | $4M | $3M | $3M | $2M | $4M | |
| SG&A Expense | $4M | $4M | $5M | $3M | $8M | $2M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $-31M | $-8M | $40M | $-4M | $8M | $3M | $16M | $7M | $11M | $10M | $7M | $7M | $6M | $5M | $5M | $7M | |
| Operating Income | $31M | $9M | $-40M | $4M | $-8M | $-3M | $-19M | $-7M | $-12M | $-10M | $-7M | $-7M | $-6M | $-5M | $-5M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $678.7K | · | $679.2K | $558.0K | $454.0K | $904.2K | $177.1K | |
| Interest Income | $206.8K | $244.2K | $138.9K | $43.9K | $21.9K | $35.3K | $23.2K | $45.0K | $64.9K | $120.9K | $198.7K | $208.9K | $183.6K | · | · | · | |
| Other Non-op | $-29.8K | $90.1K | $85.6K | $131.5K | $168.8K | $3.7K | $2.8K | $1.2K | $3.0K | $-97.6K | $-18.6K | $-348.2K | $119.5K | $71.0K | $100.5K | $70.3K | |
| Net Income | $31M | $9M | $-40M | $7M | $-9M | $-3M | $-20M | $-8M | $-11M | $-11M | $-8M | $-7M | $-6M | $-6M | $-6M | $-7M | |
| EPS (Basic) | $1.01 | $0.30 | $-5.57 | $0.26 | $-2.50 | $-1.59 | $-15.34 | $-9.07 | $-16.65 | $-18.75 | $-52.66 | $-0.18 | $-0.16 | $-0.15 | $-0.16 | $-0.21 | |
| EPS (Diluted) | $0.92 | $0.26 | $-5.36 | $0.05 | $-2.50 | $-1.59 | $-15.34 | $-9.07 | $-16.65 | $-18.75 | $-52.66 | $-0.18 | $-0.16 | $-0.15 | $-0.16 | $-0.21 | |
| Shares (Basic) | 14,173,457 | 10,610,679 | · | 6,027,713 | 3,518,906 | 2,188,938 | · | 869,479 | 664,022 | 582,584 | · | 40,139,697 | 38,093,826 | 37,410,587 | · | 34,631,774 | |
| Shares (Diluted) | 17,040,392 | 12,686,142 | · | 28,951,915 | 3,518,906 | 2,188,938 | · | 869,479 | 664,022 | 582,584 | · | 40,139,697 | 38,093,826 | 37,410,587 | · | 34,631,774 | |
| EBITDA | $31M | $9M | · | $4M | $-8M | $-3M | · | $-7M | $-12M | $-10M | · | $-7M | $-6M | $-5M | · | $-7M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $7M | $6M | $8M | $8M | $4M | $2M | $7M | $2M | $8M | $15M | $21M | $17M | $18M | $23M | $17M | |
| Inventory | · | · | · | · | · | · | · | $3M | $3M | $4M | $109.8K | $50.3K | · | · | · | · | |
| Prepaid Expense | $3M | $1M | $802.3K | $862.6K | $967.0K | $1M | $645.7K | $987.8K | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | |
| Other Current Assets | $221.2K | $120.0K | $201.6K | · | $80.1K | · | $97.3K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $13M | $9M | $7M | $9M | $9M | $5M | $3M | $12M | $7M | $14M | $21M | $27M | $23M | $25M | $28M | $29M | |
| PP&E (Net) | · | · | · | · | $23.0K | · | · | $3M | $3M | $3M | $3M | $4M | $4M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $5M | $5M | · | · | $2M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $1M | $1M | · | · | $635.8K | · | |
| Intangibles | · | · | · | · | · | · | · | $6M | $6M | $6M | $2M | $2M | · | · | · | · | |
| Other Non-current Assets | $182.2K | $182.2K | $230.4K | $238.0K | · | · | $182.2K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $113M | $70M | $52M | $83M | $56M | $6M | $4M | $23M | $19M | $26M | $29M | $35M | $29M | $29M | $31M | $31M | |
| Accounts Payable | $139.1K | $428.3K | $317.9K | $1M | $901.6K | $1M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Accrued Liabilities | · | $4.6K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | $8M | $8M | $8M | $11M | $11M | $10M | $10M | $9M | $6M | $3M | $1M | $2M | $416.7K | · | |
| Current Liabilities | $6M | $4M | $3M | $4M | $10M | $15M | $16M | $16M | $16M | $16M | $10M | $7M | $4M | $5M | $5M | $11M | |
| Capital Leases | $55.6K | $132.4K | $206.6K | $341.8K | $473.2K | $597.7K | $717.5K | $836.4K | $983.8K | $1M | $1M | $1M | $2M | $1M | $907.6K | · | |
| Total Liabilities | $11M | $12M | $11M | $12M | $18M | $16M | $17M | $19M | $21M | $24M | $20M | $19M | $19M | $13M | $14M | $11M | |
| Total Debt | · | · | · | $8M | $8M | $11M | · | $10M | $10M | $9M | · | $3M | $1M | $2M | · | · | |
| Common Stock | · | · | · | $715 | $485 | $283 | · | $8.6K | $5.6K | $4.7K | $57 | $4.3K | $3.8K | $3.8K | $3.7K | $3.6K | |
| Paid-in Capital | $303M | $290M | $282M | $272M | $245M | $189M | $182M | $179M | $165M | $158M | $154M | $153M | $141M | $140M | $135M | $132M | |
| Retained Earnings | $-201M | $-232M | $-241M | $-201M | $-207M | $-199M | $-195M | $-175M | $-167M | $-156M | $-145M | $-138M | $-130M | $-124M | $-118M | $-112M | |
| Treasury Stock | · | · | $253.6K | · | · | · | · | $0 | $0 | $2M | · | $5M | $4M | $16M | $0 | · | |
| Stockholders' Equity | $102M | $58M | $41M | $71M | $37M | $-10M | $-13M | $4M | $-2M | $2M | $9M | $16M | $11M | $16M | $17M | $20M | |
| Liabilities + Equity | $113M | $70M | $52M | $83M | $56M | $6M | $4M | $23M | $19M | $26M | $29M | $35M | $29M | $29M | $31M | $31M | |
| Shares Outstanding | 15,299,832 | 11,428,482 | 8,680,005 | 7,162,659 | 4,854,827 | 2,830,546 | 1,506,369 | 86,375,958 | 55,817,921 | 47,386,349 | 569,409 | 42,898,246 | 38,169,398 | 37,991,746 | 36,668,980 | 35,525,689 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $297.8K | $287.5K | $295.4K | $247.7K | $277.5K | $318.4K | $124.1K | $63.1K | $78.5K | $83.0K | |
| Stock-based Comp | $2M | $2M | · | · | $6M | $279.6K | $164.0K | $453.0K | $541.1K | $546.2K | $572.2K | $613.0K | $493.6K | $819.1K | $890.7K | $928.7K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $236.4K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-4M | $-3M | $-3M | $-4M | $-6M | $-6M | $-8M | $-10M | $-6M | $-6M | $-5M | $-7M | $-5M | $-7M | |
| CapEx | · | · | · | · | · | · | $1 | $1.6K | $45.7K | $114.1K | $145.2K | $580.2K | $1M | $920.9K | $31.0K | $228.0K | |
| Investing Cash Flow | $-5M | $-1M | $-6M | $-20M | · | · | $-1 | $-1.6K | $-45.7K | $-114.1K | $-145.2K | $-2M | $-1M | $-838.1K | $-311.8K | $-163.3K | |
| Financing Cash Flow | $11M | $7M | $9M | $24M | $53M | $6M | $1M | $11M | $3M | $3M | $614.3K | $11M | $5M | $3M | $3M | $3M | |
| Net Change in Cash | $2M | $937.5K | $-2M | $690.9K | $4M | $2M | $-5M | $5M | $-6M | $-7M | $-6M | $3M | $-998.2K | $-4M | $-2M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-10M | · | · | · | $-8M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | · | 100.0% | · | 99.7% | · | -8055.2% | -2067.3% | · | · | · | · | · | · | · | |
| Operating Margin | 8668.8% | 3574.8% | · | 1463.8% | · | -20589.0% | · | -451195.5% | -51661.2% | -205624.4% | · | -544255.9% | · | · | · | · | |
| Net Margin | 8652.9% | 3619.2% | · | 2190.2% | · | -23665.3% | · | -485406.3% | -48856.1% | -218748.3% | · | -612582.0% | · | · | · | · | |
| EBITDA Margin | 8668.8% | 3574.8% | · | 1463.8% | · | -20589.0% | · | -451195.5% | -51661.2% | -200662.9% | · | -544255.9% | · | · | · | · | |
| ROA | 36.7% | 23.2% | · | 12.6% | -23.3% | -21.7% | · | -27.4% | -45.7% | -39.4% | · | -22.1% | -19.1% | -16.5% | · | -25.9% | |
| ROE | 44.4% | 36.2% | · | 17.8% | -49.7% | 88.2% | · | -80.9% | -271.2% | -123.9% | · | -40.6% | -36.4% | -25.2% | · | -59.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.0 | · | 2.3 | 0.9 | 0.3 | · | 0.7 | 0.5 | 0.9 | · | 4.1 | 5.7 | 5.1 | · | 2.7 | |
| Quick Ratio | 1.7 | 1.7 | · | 2.0 | 0.7 | 0.3 | · | 0.5 | 0.1 | 0.5 | · | 3.2 | 4.3 | 3.8 | · | 1.6 | |
| Debt / Equity | · | · | · | 0.1 | 0.2 | -1.1 | · | 2.7 | -4.3 | 4.8 | · | 0.2 | 0.1 | 0.1 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -15.1 | · | -9.6 | -10.7 | -12.0 | · | -40.8 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.1 | 0.3 | 0.0 | · | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.66 | $5.12 | · | $9.88 | $7.70 | $-3.43 | · | $0.04 | $-0.04 | $0.04 | · | $0.37 | $0.28 | $0.42 | · | $0.57 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.01 | · | $0.01 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.33 | · | · | · | $-2.03 | · | · | · | $-0.21 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.63 | $0.65 | · | $1.15 | $1.55 | $1.39 | · | $0.08 | $0.04 | $0.17 | · | $0.48 | $0.46 | $0.49 | · | $0.49 | |
| EPS (TTM) | $-4.13 | $-7.55 | · | $-19.38 | $-28.50 | $-42.65 | · | $-97.13 | $-88.24 | $-71.75 | · | $-0.65 | $-0.68 | $-0.74 | · | $-0.55 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $345.3K | $44.4K | $67.1K | · | $31.8K | $31.4K | · | · | · | $10M | $10M | · | $10M | |
| Net Income TTM | $7M | $-33M | · | $-26M | $-40M | $-42M | · | $-38M | $-37M | $-32M | · | $-25M | $-25M | $-26M | · | $-19M | |
| Market Cap | $48M | $39M | · | $69M | $50M | $3M | · | $3.57B | $2.65B | $3.74B | · | $5.70B | $7.24B | $10.73B | · | $5.56B | |
| Enterprise Value | · | · | · | $69M | $51M | $10M | · | $3.58B | $2.66B | $3.74B | · | $5.68B | $7.22B | $10.71B | · | · | |
| P/E | -0.8 | -0.5 | · | -0.5 | -0.4 | -0.0 | · | -0.4 | -0.5 | -1.1 | · | -204.3 | -278.8 | -381.6 | · | -284.4 | |
| P/S | 34.3 | 37.8 | · | 198.7 | 1134.0 | 46.4 | · | 112230.1 | 84460.0 | · | · | · | 723.7 | 1072.9 | · | 555.6 | |
| P/B | 0.5 | 0.7 | · | 1.0 | 1.3 | -0.3 | · | 960.5 | -1119.2 | 2056.3 | · | 361.0 | 687.8 | 678.4 | · | 273.3 | |
| P / Tangible Book | 0.5 | 0.7 | · | 1.0 | 1.3 | · | · | · | · | · | · | 417.1 | 687.8 | 678.4 | · | 273.3 | |
| P / Cash Flow | · | -9.4 | · | · | · | -0.7 | · | · | · | -377.9 | · | · | · | -1541.8 | · | · | |
| EV / Revenue | · | · | · | 198.8 | 1148.4 | 148.6 | · | 112320.5 | 84713.3 | · | · | · | 722.0 | 1071.3 | · | · | |
| Earnings Yield | -131.5% | -218.8% | · | -202.3% | -274.6% | -3877.3% | · | -234.8% | -185.7% | -91.0% | · | -0.49% | -0.36% | -0.26% | · | -0.35% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $813.5K | $57.3K | $3.8K | · | $14M |
| Margen Bruto % | 62.7% | · | · | · | 88.6% |
| Margen Operativo % | -5743.5% | · | · | · | -92.2% |
| Beneficio neto | $-45M | $-50M | $-27M | $-28M | $-13M |
| EPS Diluido | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.2 | · | · | · | · |
| Ratio corriente | 2.7 | · | · | · | 2.0 |
| Ratio Rápido | 2.4 | · | · | · | 1.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | · | · | · | $-22M |
Propietarios institucionales (13F) 37 declarantes · $11.2M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
37
Valor en tenencia
$11.2M
Nuevas posiciones
10
Posiciones cerradas
5
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 10 (+4 vs trimestre anterior) | 5 (-1 vs trimestre anterior) | 9 (+3 vs trimestre anterior) | 6 (+1 vs trimestre anterior) | +1.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| LASRY MARC | $2 300 388 | 240 124 | 20,47% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 465 746 | 466 798 | 13,05% | Acciones |
| FRANKLIN RESOURCES INC | $1 243 248 | 395 939 | 11,07% | Acciones |
| Arrington Capital Management, LLC | $935 020 | 297 777 | 8,32% | Acciones |
| MORGAN STANLEY | $747 276 | 237 986 | 6,65% | Acciones |
| Redwood Wealth Management Group, LLC | $632 292 | 183 273 | 5,63% | Acciones |
| Almanack Investment Partners, LLC. | $530 701 | 169 013 | 4,72% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $410 467 | 130 707 | 3,65% | Acciones |
| JANE STREET GROUP, LLC | $400 321 | 127 491 | 3,56% | Acciones |
| OPPENHEIMER & CO INC | $396 786 | 126 365 | 3,53% | Acciones |
| BlackRock, Inc. | $359 216 | 114 400 | 3,20% | Acciones |
| VANGUARD GROUP INC | $306 373 | 86 060 | 2,73% | Acciones |
| GOLDMAN SACHS GROUP INC | $286 965 | 91 390 | 2,55% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $233 789 | 74 455 | 2,08% | Acciones |
| CITADEL ADVISORS LLC | $176 779 | 56 299 | 1,57% | Acciones |
| STATE STREET CORP | $170 681 | 54 357 | 1,52% | Acciones |
| Cubist Systematic Strategies, LLC | $140 290 | 14 644 | 1,25% | Acciones |
| UBS Group AG | $104 182 | 33 179 | 0,93% | Acciones |
| NORTHERN TRUST CORP | $97 013 | 30 896 | 0,86% | Acciones |
| PEAK6 LLC | $62 800 | 20 000 | 0,56% | Acciones |
| INVESTMENT HOUSE LLC | $54 322 | 17 300 | 0,48% | Acciones |
| JPMORGAN CHASE & CO | $51 220 | 16 107 | 0,46% | Acciones |
| XTX Topco Ltd | $38 587 | 12 289 | 0,34% | Acciones |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | $34 933 | 11 125 | 0,31% | Acciones |
| Sanctuary Advisors, LLC | $33 912 | 10 800 | 0,30% | Acciones |
| BARCLAYS PLC | $5 674 | 1 807 | 0,05% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $5 410 | 1 768 | 0,05% | Acciones |
| WELLS FARGO & COMPANY/MN | $3 862 | 1 230 | 0,03% | Acciones |
| SBI Securities Co., Ltd. | $3 828 | 1 219 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $2 675 | 852 | 0,02% | Acciones |
| Vanguard Global Advisers, LLC | $311 | 99 | 0,00% | Acciones |
| 10Elms LLP | $283 | 90 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $170 | 54 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $65 | 20 500 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $13 | 4 | 0,00% | Acciones |
| CITIGROUP INC | $3 | 1 | 0,00% | Acciones |
| GROUP ONE TRADING LLC | $3 | 1 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 6 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Avenue Venture Opportunities Fund, L.P., Avenue Venture Opportunities Fund II, L.P., Avenue Capital Management II, L.P., Avenue Venture Opportunities Partners, LLC, Avenue Venture Opportunities Partners II, LLC, GL Venture Opportunities Partners, LLC, GL Venture Opportunities Partners II, LLC, Marc Lasry ×7 presentaciones | 19 de septiembre de 2025 | 4,20% | Enmienda | · | SEC |
| Hyunsu Jung | 16 de julio de 2025 | 9,30% | Presentación inicial | Inversión pasiva | SEC |
| Stuart M. Grant ×7 presentaciones | 4 de diciembre de 2024 | · | Presentación inicial | · | SEC |
| Tsontcho Ianchulev ×8 presentaciones | 18 de julio de 2024 | · | Presentación inicial | · | SEC |
| Fred Eshelman ×5 presentaciones | 13 de febrero de 2023 | · | Presentación inicial | · | SEC |
| Shuhei Yoshida, Senju Pharmaceutical Co., Ltd. ×2 presentaciones | 24 de agosto de 2021 | · | Presentación inicial | Campaña de la junta directiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 26 insiders · 9 directivos · 17 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Hyunsu Jung | Chief Executive Officer and Chief Investment Officer | 16 de agosto de 2026 F | 1 345 676 | 4 | 0 | $29 580 |
| Michael M Rowe | Chief Executive Officer | 13 de junio de 2025 A | 7 975 | 0 | 0 | $0 |
| David R. Knox | Chief Financial Officer | 29 de septiembre de 2026 F | 287 556 | 1 | 0 | $100 340 |
| Andrew D. Jones | Chief Financial Officer | 30 de agosto de 2024 A | · | 0 | 0 | $0 |
| John P Gandolfo | Chief Financial Officer | 12 de febrero de 2024 A | 8 000 | 0 | 0 | $0 |
| Bren Kern | Chief Operating Officer | 21 de abril de 2025 A | 50 031 | 0 | 0 | $0 |
| Robert Rubenstein | General Counsel | 12 de enero de 2026 A | 75 000 | 0 | 0 | $0 |
| Jennifer G Clasby | VP, Regulatory and Clinical | 17 de junio de 2021 M | 66 537 | 0 | 0 | $0 |
| Luke Clauson | VP Research & Development | 16 de junio de 2021 A | · | 0 | 0 | $0 |
| Rachel Jacobson | Consejero | 30 de junio de 2026 A | 115 218 | 0 | 0 | $0 |
| Happy David Walters | Consejero | 30 de junio de 2026 A | 170 847 | 1 | 0 | $187 029 |
| Ellen R Strahlman | Consejero | 30 de junio de 2026 A | 150 078 | 6 | 0 | $233 797 |
| Michael S Geltzeiler | Consejero | 30 de junio de 2026 A | 146 932 | 1 | 0 | $90 300 |
| Ram Palanki | Consejero | 21 de abril de 2025 A | 4 235 | 0 | 0 | $0 |
| Tsontcho Ianchulev | Consejero | 21 de abril de 2025 A | 10 122 | 0 | 0 | $0 |
| Charles E Mather IV | Consejero | 21 de abril de 2025 A | 9 950 | 0 | 0 | $0 |
| Julia A Haller | Consejero | 16 de junio de 2022 A | 30 408 | 0 | 0 | $0 |
| Kenneth B Lee JR | Consejero | 16 de junio de 2022 A | 64 544 | 0 | 0 | $0 |
| Stephen Keith Benjamin | Consejero | 11 de abril de 2022 A | 25 511 | 0 | 0 | $0 |
| Curt H Labelle | Consejero | 17 de noviembre de 2021 A | 42 236 | 0 | 0 | $0 |
| Anthony Y Sun | Consejero | 17 de noviembre de 2021 A | 26 322 | 0 | 0 | $0 |
| Ernest Mario | Consejero | 17 de noviembre de 2021 A | 382 706 | 0 | 0 | $0 |
| Fredric N Eshelman | Consejero | 17 de noviembre de 2021 A | 1 299 750 | 0 | 0 | $0 |
| Shuhei Yoshida | Consejero | 14 de mayo de 2019 M | 33 334 | 0 | 0 | $0 |
| Stuart M. Grant | Propietario del 10% | 2 de julio de 2024 J | 10 914 153 | 0 | 0 | $0 |
| Senju Pharmaceutical Co., Ltd. | Propietario del 10% | 29 de enero de 2018 P | 1 718 566 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| SATO · Invesco Exchange-Traded Fund Trust … | 2,07% | 47 988 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,01% | 33 775 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 176 041 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 290 757 SH | 19 de agosto de 2026 | Diario |
HYPD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 8 analistas
COMPRA
Objetivo mediano
$9.82
+163,4%
2 25,0%
Compra fuerte
5 62,5%
Compra
1 12,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
2 analistas · 2026-10-01Objetivo medio $9.82 +163,4%
← Por Debajo de Todos los Objetivos
Precio Actual $3.73
Mín$8.45
Media$9.82
Máx$11.20
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| RFL | · | -1.6 | 44.0% | -3328.2% | -34.6% | · |
| CING | · | · | · | · | · | · |
| PLRX | $75M | -0.5 | -83.7% | · | -74.4% | · |
| ELOX | · | · | · | · | 30.1% | · |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
| IMA | · | -0.7 | -77.1% | -5668.6% | 192.1% | · |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 13, 2026